Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy

Oncotarget

Volumn 8, Issue 15, 2017, Pages 25131-25140

  Aleksova, Aneta ^a   Beltrami, Antonio Paolo ^b   Carriere, Cosimo ^a   Barbati, Giulia ^a   Lesizza, Pierluigi ^a   Perrieri Montanino, Martina ^a   Isola, Miriam ^b   Gentile, Piero ^a   Salvioni, Elisabetta ^c   Not, Tarcisio ^e   Agostoni, Piergiuseppe ^c,d   Sinagra, Gianfranco ^a  

^a UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c CENTRO CARDIOLOGICO MONZINO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Brain natriuretic peptide; Heart failure; Idiopathic dilated cardiomyopathy; Interleukin 1 beta; Long term outcome

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; SODIUM;

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTPATIENT; PREDICTION; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEX DIFFERENCE; AMBULATORY CARE; BLOOD; COMORBIDITY; HEART FUNCTION TEST; MORTALITY; OUTCOME ASSESSMENT; TIME FACTOR;

AMBULATORY CARE; BIOMARKERS; CARDIOMYOPATHY, DILATED; COMORBIDITY; FEMALE; HEART FUNCTION TESTS; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-1BETA; MALE; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; ROC CURVE; TIME FACTORS;

EID: 85017531851     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.15349     Document Type: Article

References (20)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, and American Heart Association, and Council on Clinical Cardiology, Heart Failure and Transplantation Committee, and Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, and Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113:1807-16.
2. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol. 1992; 69:1458-66.
3. Toldo S, Mezzaroma E, Mauro AG, Salloum F, Van Tassell BW, Abbate A. The inflammasome in myocardial injury and cardiac remodeling. Antioxid Redox Signal. 2015; 22:1146-61.
4. Luo B, Wang F, Li B, Dong Z, Liu X, Zhang C, An F. Association of nucleotide-binding oligomerization domainlike receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy. Clin Chem Lab Med. 2013; 51:1521-28.
5. Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. Targeting interleukin-1 in heart disease. Circulation. 2013; 128:1910-23.
6. Van Tassell BW, Arena RA, Toldo S, Mezzaroma E, Azam T, Seropian IM, Shah K, Canada J, Voelkel NF, Dinarello CA, Abbate A. Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS One. 2012; 7:e33438.
7. Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010; 17:314-21.
8. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006; 113:876-90.
9. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011; 117:3720-32.
10. Fontes JA, Rose NR, Ciháková D. The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine. 2015; 74:62-68.
11. Bielecka-Dabrowa A, von Haehling S, Aronow WS, Ahmed MI, Rysz J, Banach M. Heart failure biomarkers in patients with dilated cardiomyopathy. Int J Cardiol. 2013; 168:2404-10.
12. Verbrugge FH, Steels P, Grieten L, Nijst P, Tang WH, Mullens W. Hyponatremia in acute decompensated heart failure: depletion versus dilution. J Am Coll Cardiol. 2015; 65:480-92.
13. Rusinaru D, Tribouilloy C, Berry C, Richards AM, Whalley GA, Earle N, Poppe KK, Guazzi M, Macin SM, Komajda M, Doughty RN, Investigators M, and MAGGIC Investigators. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(+): Meta-Analysis Global Group in Chronic heart failure (MAGGIC). Eur J Heart Fail. 2012; 14:1139-46.
14. Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T. Prognostic utility of B-type natriuretic peptide assessment in stable lowrisk outpatients with nonischemic cardiomyopathy after decompensated heart failure. J Am Coll Cardiol. 2008; 51:2329-35.
15. Miller WL, Burnett JC Jr, Hartman KA, Henle MP, Burritt MF, Jaffe AS. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict shortterm mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol. 2005; 96:837-41.
16. Sun T, Wang L, Zhang Y. Prognostic value of B-type natriuretic peptide in patients with chronic and advanced heart failure. Intern Med J. 2007; 37:168-71.
17. Huang B, Shen J, Li L, Huang Y, Luo S. Effect of B-Type Natriuretic Peptide Level on Long-Term Outcome in Patients With End-Stage Heart Failure. Am J Cardiol. 2016; 118:383-88.
18. Oremus M, Don-Wauchope A, McKelvie R, Santaguida PL, Hill S, Balion C, Booth R, Brown JA, Ali U, Bustamam A, Sohel N, Raina P. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev. 2014; 19:471-505.
19. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996; 93:841-42.
20. Blanche P, Dartigues JF, Jacqmin-Gadda H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013; 32:5381-97.